×
0.0229312063808575 0.0229312063808575 0.0229312063808575 0.0229312063808575 0.0229312063808575 0.0229312063808575 0.0229312063808575 0.0229312063808575
Stockreport

France's Cellectis wins U.S patents for gene editing technology [Reuters]

CELLECTIS SA AMERICAN DEPOSI (CLLS)  More Company Research Source: Reuters
Last cellectis sa american deposi earnings: 5/9 04:31 pm Check Earnings Report
US:NASDAQ Investor Relations: cellectis.com/en/investors
PDF France's Cellectis wins U.S patents for gene editing technology | Reuters Reuters Staff 2 Min Read PARIS (Reuters) - The United States has granted French cell therapy group Cellectis two patents to deploy a technology known as CRISPR in T cells, which play a key role in the immune response to cancer, the company said on Tuesday. The patents come on the back of another granted last year by the European Patent Office. Cellectis said it intended to make the three patents available for future licensing deals. The gene therapy sector has generated fierce patent disputes in recent months, as well as merger and acquisition activity. “These inventions are based on the early work initiated by inventors at Cellectis when the CRISPR technology first came to light,” the company said. CRISPR, an abbreviation of Clustered Regularly Interspaced Short Palindromic Repeats, forms the basis of techniques known as CRISPR/Cas9 or Cpf1 that modify the structures of genes within living organisms. In spite o [Read more]

IMPACT SNAPSHOT EVENT TIME: CLLS
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
POST NEWS RANGE
%
PRICE CHANGE

PRICE CHANGE PERCENTAGE


S&P 500 (SPX)

%

VOLUME RATIO
%

VOLUME (SHARES)
TICKS

AVG SHARES PER TRADE

Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Opt-in for
CLLS alerts
from News Quantified